TrialPLoS medicine2017

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Robert Molokie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.